A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease

NCT03246399 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Study stopped due to business reasons, following full enrollment of the first dose cohort.

Conditions

Interventions

Sponsor

Biosplice Therapeutics, Inc.